[1] Porras C, Bennett C, Safaeian M, et al. Determinants of seropositivity among HPV16/18 DNA positive young women[J]. BMC Infect Dis, 2010, 10:238243
[2] 曹振东, 白慧杰, 韩冰, 等. 64排螺旋CT对宫颈癌的诊断及分期价值[J]. 河北医药, 2009, 31(16):20482050.
[3] 钱昊初, 郭文立, 王思亮, 等. 宫颈癌Aquilion ONE 320 CT灌注成像表现初探[J]. 中国临床医学影像杂志, 2012, 23(12):853855.
[4] 李相生, 周纯武, 戴景蕊, 等. 多层螺旋CT诊断宫颈癌淋巴结转移的价值[J]. 中国医学影像学杂志, 2008, 1(16):6163.
[5] Shweel MA, AbdelGawad EA, AbdelGawad EA, et al. Uterine cervical malignancy:diagnostic accuracy of MRI with histopathologic correlation[J]. J Clin Imaging Sci, 2012, 2:42.
[6] Kraljevi′c Z, Viskovi′c K, Ledinsky M, et al. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings[J]. Coll Antropol, 2013, 37(2):561568.
[7] Zand KR, Reinhold C, Abe H, et al. Magnetic resonance imaging of the cervix[J]. Cancer Imaging, 2007, 7:6976.
[8] Nicolet V, Carignan L, Bourdon F, et al. MR imagingof clinical stage I and IIa cervical carcinoma:A practical staging approach[J]. Radiographics, 2000, 20(6):15391549.
[9] Freeman SJ, Aly AM, Kataoka MY, Addley HC, et al. The revised FIGO staging system for uterine malignancies:implications for MR imaging[J]. Radiographics, 2012, 32(6):18051827.
[10] Dhoot NM, Kumar V, Shinagare A, et al. Evaluation of carcinoma cervix using magnetic resonance imaging:correlation with clinical FIGO staging and impact on management[J]. Med Imaging Radiat Oncol, 2012, 56(1):5865.
[11] Collecttini F, Hamm B. Uterine cervical cancer:preoperative staging with magnetic resonance imaging[J]. Radiologe, 2011, 51(7):589595.
[12] Tatsumi M, Cohade C, Bristow RE, et al. Imaging Uterine cervical cancer with FDGPET/CT direct comparison with PET[J]. Mol Imaging Biol, 2009, 11(4):229235.
[13] Chao A, Ho KC, Wang C, et al. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patient with limited distant lymph node metastases[J]. Gynecol Oncol, 2008, 110(2):172178.
[14] Kima SK, Choia HJ, Parka SY, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients[J]. Eur J Cancer, 2009, 45(12):21032109.
[15] Choi EK, Kim JK, Choi HJ, et al. Nodebynode correlation between MR and PET/CT in patients with uterine cercival cancer:diffusion weighted imaging versus sizebased criteria on T2WI[J]. Eur Radiol, 2009, 19(8):20242032.
[16] Engin G, Kucucuk S, Olemz H, et al. Corralation of clinical and MRI staging in cervical carcinoma treated with radiation therapy :A singlecenter eaperience[J]. Diagn Interv Radiol, 2011, 17(1):4451.
[17] Hori M, Kim T, Murakami T, et al. Uterine cervical carcinoma:preoperative staging with 3.0TMR imaging comparison with 1.5TMR imging[J]. Radiology, 2009, 251(1):96104.
[18] Soussan M, Wartski M, Cherel P, et al. Impact of FDG PETCT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence[J]. Gynecol Oncol, 2008, 108(1):160165.
[19] Chung HH, Jo H, Kang WJ, et al .Clinical impact of PETCT on the management of suspected cervical cancer recurrence[J]. Gynecol Oncol, 2010, 104(3):529534.
[20] EvenSapir E, Inbar M. PET in women with high risk for breast or ovarian cancer[J]. Lancet Oncol, 2010, 11(9):899905. |